Meningiomas may show a different WHO grade and variable biological and clinical behaviors. The aim of the present study is to assess whether WHO grade, proliferation index, progesterone receptor (PR) expression, histological subtype, neuroradiological features, and the recurrence rate differ depending on the tumor location
BACKGROUND: Meningiomas are the most common benign CNS neoplasms with higher prevalence in women. ...
Emerging evidence emphasizes the prognostic importance of meningioma location. The present investiga...
Meningioma is a tumor that arises from the meningothelial cells of the arachnoid membranes which are...
Meningiomas may show a different WHO grade and variable biological and clinical behaviors. The aim o...
Meningiomas are slow-growing neoplasms which recur locally, their morphologic grading is simple but ...
Meningiomas are slow-growing neoplasms which recur locally, their morphologic grading is simple but ...
Background: The progesterone receptor (PR) is variably expressed in most meningiomas and was found t...
Background Meningioma is the most intracranial tumor in human. Eventhough most of cases are benign m...
Objectives: Meningiomas are generally benign central nervous system neoplasms, which frequently expr...
Context: Five year rate for recurrence of symptoms regardless of method of treatment is 19.2% for be...
Background: Meningiomas are slow growing intracranial and intraspinal neoplasms with a tendency to r...
BACKGROUND: Meningiomas are heterogeneous, with differences in anatomical, histopathological, and cl...
Background: Meningioma is a primary intracranial benign tumor that is affected by the balance of the...
(Conclusion) Although the proliferative markers and hormonal (progesterone) receptor status of menin...
Meningiomas are, in most cases, low grade intracranial tumors. However, relapses are frequent. To da...
BACKGROUND: Meningiomas are the most common benign CNS neoplasms with higher prevalence in women. ...
Emerging evidence emphasizes the prognostic importance of meningioma location. The present investiga...
Meningioma is a tumor that arises from the meningothelial cells of the arachnoid membranes which are...
Meningiomas may show a different WHO grade and variable biological and clinical behaviors. The aim o...
Meningiomas are slow-growing neoplasms which recur locally, their morphologic grading is simple but ...
Meningiomas are slow-growing neoplasms which recur locally, their morphologic grading is simple but ...
Background: The progesterone receptor (PR) is variably expressed in most meningiomas and was found t...
Background Meningioma is the most intracranial tumor in human. Eventhough most of cases are benign m...
Objectives: Meningiomas are generally benign central nervous system neoplasms, which frequently expr...
Context: Five year rate for recurrence of symptoms regardless of method of treatment is 19.2% for be...
Background: Meningiomas are slow growing intracranial and intraspinal neoplasms with a tendency to r...
BACKGROUND: Meningiomas are heterogeneous, with differences in anatomical, histopathological, and cl...
Background: Meningioma is a primary intracranial benign tumor that is affected by the balance of the...
(Conclusion) Although the proliferative markers and hormonal (progesterone) receptor status of menin...
Meningiomas are, in most cases, low grade intracranial tumors. However, relapses are frequent. To da...
BACKGROUND: Meningiomas are the most common benign CNS neoplasms with higher prevalence in women. ...
Emerging evidence emphasizes the prognostic importance of meningioma location. The present investiga...
Meningioma is a tumor that arises from the meningothelial cells of the arachnoid membranes which are...